USNA$20.66
$23.45
Chart
Performance
Key Stats
AI USNA Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyUSANA Health Sciences (USNA) exhibits strong fundamental health with a focus on nutritional products and a solid financial position. While the stock has experienced recent underperformance, its profitability and market position present opportunities for long-term investors. Technicals suggest short-term caution but a potential for recovery.
Thematic
USANA operates in the health and wellness sector, benefiting from growing consumer interest in nutrition and self-care. The direct-selling model provides a scalable distribution channel, though competition and regulatory landscapes are key considerations.
Fundamental
USANA Health Sciences demonstrates robust profitability and a healthy balance sheet. Despite a recent decline in revenue and net income, the company maintains strong margins and a solid cash position, indicating operational resilience. The valuation appears attractive based on historical P/E and P/S ratios.
Technical
USANA's stock price has been in a downtrend, trading below key moving averages. While some oscillators suggest oversold conditions and potential for a bounce, the overall trend and recent performance indicate caution. Support levels should be watched closely.
| Factor | Score |
|---|---|
| Health & Wellness Trends | 85 |
| Direct Selling/Network Marketing | 65 |
| Global Expansion | 75 |
| Regulatory Landscape (Supplements/Direct Selling) | 50 |
| Competitive Intensity | 65 |
| Factor | Score |
|---|---|
| Valuation | 75 |
| Profitability | 70 |
| Growth | 40 |
| Balance Sheet Health | 95 |
| Cash Flow | 80 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 50 |
| Volume Confirmation | 60 |
| Support & Resistance | 65 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Positive EPS Surprises
The company has demonstrated a pattern of beating earnings per share (EPS) estimates, with 7 out of the last 12 reported quarters exceeding expectations. The latest quarter (2025 Q2) saw reported EPS of $0.73 against an estimate of $0.70, a positive surprise of 4.29%.
Consistent Revenue Growth
While revenue has seen a decline in recent periods (2024Q4: $213.6M vs. 2023Q4: $224.1M), the company has a history of significant revenue generation. The TTM revenue stands at $854.5M.
Bearish Points (7)
Deteriorating Valuation Ratios
The Price-to-Sales (P/S) ratio has increased from 0.6 in 2023 to 0.8 TTM, and quarterly P/S ratios are also showing an upward trend (e.g., 2025 Q1 at 2.0). This suggests that the market is valuing the company's sales more highly, potentially indicating overvaluation if sales don't materialize.
Revenue Decline
The company experienced a revenue decline from Q4 2023 ($224.1M) to Q4 2024 ($213.6M), a year-over-year decrease of approximately 4.7%. This indicates a contraction in sales, which could impact future earnings.
Calendar
October 2025
22
Next Earnings Date
H: $0.47
A: $0.47
L: $0.47
H: 224.13M
A: 224.13M
L: 224.13M
Profile
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Seasonals
Price Target
61.00 USD
The 39 analysts offering 1 year price forecasts for USNA have a max estimate of 61.00 and a min estimate of 61.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Direct multi-level marketing (MLM) competitor primarily focused on nutritional supplements, weight management, and personal care products, with a similar global distribution model.
Weight: 90
Direct multi-level marketing (MLM) competitor offering a broad range of premium beauty and wellness products, including nutritional supplements and personal care.
Weight: 88
Direct competitor in the nutritional and herbal supplement industry, also operating through a direct sales model globally.
Weight: 85
Smaller direct selling company in the health and wellness sector, offering nutritional supplements and skincare products.